ValiRx monitors working capital position amid talks to end subscription agreement with investor

03:45 EDT 10 Jun 2019 | Proactive Investors

ValiRX said it expects to announce the outcome of talks with European High Growth “shortly” and no longer intends to enter into further arrangements with the investor.

More From BioPortfolio on "ValiRx monitors working capital position amid talks to end subscription agreement with investor"